Because USP9X affects cell migration and angiogenesis by elevating CCND1-mediated SOX11 expression, USP9X suppression leads to the downregulation of USP9X protein levels in Z-138 and Jeko-1 cell lines and inhibits tumor development in mice in vivo. Here, SOX11 is linked to neoplasm.